Phone
Address Talkabouturology, Nizhny Novgorod, Russia
Skype ukitcom
Email Talkabouturology@list.ru
                                    Talk about urology

Back to the list

Most men with metastatic castration-sensitive prostate cancer (mCSPC) in 2018 did not receive advanced therapies in addition to androgen deprivation therapy (ADT) as first-line treatment for their disease as recommended by clinical practice guidelines

https://www.renalandurologynews.com/home/news/urology/prostate-cancer/docetaxel-novel-hormonal-therapies-underused-first-line-metastatic-prostate-cancer-treatment/?utm_source=social&utm_medium=facebook&utm_content=a51f55e8-4296-429e-945c-c5364e79e366&utm_campaign=run_daily_posts